Cite

HARVARD Citation

    Zhou, H. et al. (2016). Clinical performance of the Food and Drug Administration–Approved high‐risk HPV test for the detection of high‐grade cervicovaginal lesions. Cancer cytopathology. 124 (5), pp. 317-323. [Online]. 
  
Back to record